Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH MEDIA
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC

Bead-Based Assay Kits to Boost Metabolic and Hormone Research

By BiotechDaily International staff writers
Posted on 28 Jul 2014
Bio-Rad\'s Bio-Plex Pro RBM Magnetic Bead-Based Assay
The Bio-Plex Pro RBM Magnetic Bead-Based Assay (Photo courtesy of BIO-RAD LABORATORIES)
A new line of magnetic bead, microtiter plate-based metabolic assay kits is now available for use by biotech and other life science researchers.

The Bio-Rad Laboratories, Inc. (Hercules, CA, USA) Bio-Plex Pro RBM Human Metabolic and Hormone Assay line comprises kits for the analysis of seven panels of highly relevant biomarkers involved in diabetes, obesity, metabolic syndrome, cardiovascular disease (CVD), and hormonal control of metabolism and reproductive organs. The kits were developed in partnership with Myriad RBM, Inc., (Austin, TX, USA).

In the standard format, each kit contains one 96-well microtiter plate, magnetic capture beads, detection antibodies, standards, two-level controls, diluent, buffers, streptavidin-PE, and plate seals for the detection of up to eight human metabolic markers.

The assays are built on a magnetic bead platform, which allows data to be reported within three and a half hours. The kit format enables robust quantification of multiple proteins in human serum, plasma, and cell culture media samples. Kits are offered for research involving gut hormones and adipokines, pituitary hormones, diabetes (type I and type II), metabolic syndrome, obesity, CVD, and inflammation.

The Bio-Plex Pro RBM Human Metabolic and Hormone Assay line of kits is compatible with the Bio-Plex 100/200, Bio-Plex 3D, and Bio-Plex MAGPIX analytical platforms, as well as all other Luminex-based xMAP instruments and software.

Related Links:
Bio-Rad Laboratories, Inc.
Myriad RBM, Inc.




Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to BiotechDaily.com and get complete access to news and events that shape the world of biotechnology.
Free digital version edition of Bio Research International sent by email on regular basis
Free print version of Bio Research International magazine
(available only outside USA and Canada).
Free and unlimited access to back issues of Bio Research International in digital format
Free Bio Research International Newsletter sent every 2 weeks containing the latest news
Free breaking news sent via email
Free access to Events Calendar
Free access to LinkXpress new product services
REGISTRATION IS FREE AND EASY!


Click here to Register

Sign in: Registered website members
Username: Password:
Forgot username/password? Click here!
Sign in: Registered magazine subscribers
Subcode: Last Name:
What is SUBCODE?


Channels

Genomics/Proteomics

view channel
Image: In mice, mitochondria (green) in healthy (left) and Mfn1-deficient heart muscle cells (center) are organized in a linear arrangement, but the organelles are enlarged and disorganized in Mfn2-deficient cells (right) (Photo courtesy of the Rockefeller Press).

Cell Biologists Find That Certain Mitochondrial Diseases Stem from Coenzyme Q10 Depletion

A team of German cell biologists has linked the development of certain mitochondrial-linked diseases to depletion of the organelles' pool of coenzyme Q10 brought about by mutation in the MFN2 gene, which... Read more

Drug Discovery

view channel
Image: Molecular model of the protein Saposin C (Photo courtesy of Wikimedia Commons).

Nanovesicles Kill Human Lung Cancer Cells in Culture and in a Mouse Xenograft Model

Nanovesicles assembled from the protein Saposin C (SapC) and the phospholipid dioleoylphosphatidylserine (DOPS) were shown to be potent inhibitors of lung cancer cells in culture and in a mouse xenograft model.... Read more

Biochemistry

view channel

Possible New Target Found for Treating Brain Inflammation

Scientists have identified an enzyme that produces a class of inflammatory lipid molecules in the brain. Abnormally high levels of these molecules appear to cause a rare inherited eurodegenerative disorder, and that disorder now may be treatable if researchers can develop suitable drug candidates that suppress this enzyme.... Read more

Business

view channel

Roche Acquires Signature Diagnostics to Advance Translational Research

Roche (Basel, Switzerland) will advance translational research for next generation sequencing (NGS) diagnostics by leveraging the unique expertise of Signature Diagnostics AG (Potsdam, Germany) in biobanks and development of novel NGS diagnostic assays. Signature Diagnostics is a privately held translational oncology... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.